Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03563222
Recruitment Status : Not yet recruiting
First Posted : June 20, 2018
Last Update Posted : September 4, 2019
Sponsor:
Information provided by (Responsible Party):
Fresenius Kabi

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020